Dermata Therapeutics Warrant Stock Probability of Future Stock Price Finishing Over 52.98
| DRMAW Stock | USD 0.01 0 19.57% |
Dermata |
Dermata Therapeutics Target Price Odds to finish over 52.98
The tendency of Dermata Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 52.98 or more in 90 days |
| 0.01 | 90 days | 52.98 | close to zero percent |
Based on a normal probability distribution, the odds of Dermata Therapeutics to move over $ 52.98 or more in 90 days from now is close to zero percent (This Dermata Therapeutics Warrant probability density function shows the probability of Dermata Stock to fall within a particular range of prices over 90 days) . Probability of Dermata Therapeutics price to stay between its current price of $ 0.01 and $ 52.98 at the end of the 90-day period is about 47.12 .
Assuming the 90 days horizon the stock has the beta coefficient of 1.47 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Dermata Therapeutics will likely underperform. Moreover Dermata Therapeutics Warrant has an alpha of 1.0754, implying that it can generate a 1.08 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Dermata Therapeutics Price Density |
| Price |
Predictive Modules for Dermata Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dermata Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Dermata Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Dermata Therapeutics is not an exception. The market had few large corrections towards the Dermata Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Dermata Therapeutics Warrant, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Dermata Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.08 | |
β | Beta against Dow Jones | 1.47 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.05 |
Dermata Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Dermata Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Dermata Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Dermata Therapeutics is way too risky over 90 days horizon | |
| Dermata Therapeutics has some characteristics of a very speculative penny stock | |
| Dermata Therapeutics appears to be risky and price may revert if volatility continues | |
| Dermata Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Dermata Therapeutics generates negative cash flow from operations | |
| Dermata Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Dermata Secures Key Patent for Revolutionary Acne Treatment DMT310 Ahead of Phase 3 Results - StockTitan |
Dermata Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Dermata Stock often depends not only on the future outlook of the current and potential Dermata Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dermata Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 195 K | |
| Cash And Short Term Investments | 7.4 M |
Dermata Therapeutics Technical Analysis
Dermata Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Dermata Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Dermata Therapeutics Warrant. In general, you should focus on analyzing Dermata Stock price patterns and their correlations with different microeconomic environments and drivers.
Dermata Therapeutics Predictive Forecast Models
Dermata Therapeutics' time-series forecasting models is one of many Dermata Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Dermata Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Dermata Therapeutics
Checking the ongoing alerts about Dermata Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Dermata Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Dermata Therapeutics is way too risky over 90 days horizon | |
| Dermata Therapeutics has some characteristics of a very speculative penny stock | |
| Dermata Therapeutics appears to be risky and price may revert if volatility continues | |
| Dermata Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.79 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Dermata Therapeutics generates negative cash flow from operations | |
| Dermata Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Dermata Secures Key Patent for Revolutionary Acne Treatment DMT310 Ahead of Phase 3 Results - StockTitan |
Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.